As employee #5 at Eskalera, an early-stage HR SaaS startup, I was brought in to architect and operationalize the company’s entire brand and go-to-market (GTM) strategy from the ground up. With no existing marketing infrastructure and a fragmented product vision from four co-founders, I led the charge to define market fit, align internal stakeholders, and launch within just four months.
Strategic Impact & Achievements:
$7M+ Sales Pipeline: Built a scalable GTM engine that generated over $7M in qualified pipeline in under two years without any paid advertising.
Brand Creation & Market Entry: Crafted Eskalera’s full brand identity, visual design, website, messaging architecture, and content strategy, executing a full-market launch in under four months.
First Client Win (Cornell University): Launched lead gen campaigns that brought in the company’s first inbound lead, converting it into a signed enterprise contract during the launch phase.
Lean & Agile Marketing Execution: Led multichannel initiatives across email, social, webinars, and PR, achieving a 29% email CTR, 10% social traffic increase, and 3,000+ opportunities from organic and event-driven outreach.
Category Creation & Thought Leadership: Positioned Eskalera as a next-gen DEI and employee engagement platform, leading PR efforts that secured placements in WSJ, Yahoo Finance, and Business Insider.
Innovative Campaigns:
Rapid COVID-19 Response Campaign: Launched a 10-day campaign offering free access to the platform, driving 60+ inbound leads and 15 new clients in 72 hours.
Mentorship & Product Expansion: Partnered with the product team to define and launch features like “Mentoring Circles,” aligning GTM messaging with user needs and organizational vision.
Leadership & Collaboration:
Sole marketing lead reporting to the CEO.
Led cross-functional alignment across engineering, product, sales, client success, and PR.
Implemented agile GTM sprints and marketing ops via HubSpot and Salesforce.
Bringing clarity in chaos
I specialize in transforming abstract vision into executable strategy, aligning stakeholders, launching brands, and driving tangible growth in early-stage environments.
At Babylon Health, I spearheaded the development and execution of a nationwide go-to-market (GTM) strategy focused on Medicaid populations, resulting in a 9% increase in member activation within just 90 days. Tasked with scaling engagement in historically underserved regions, I stepped into a newly created role to bridge communication gaps across marketing, product, and clinical teams.
Strategic Leadership & Execution:
GTM & Field Marketing Launch
Built and launched a grassroots field marketing program in under three months across Missouri, Georgia, and Mississippi. This included hiring and managing a five-person team, designing localized outreach strategies, and executing on-the-ground activation initiatives.
Cross-Functional Collaboration
Served as a liaison between 30+ stakeholders, aligning health plan KPIs with co-branded messaging and activation touchpoints, spanning digital, community, and offline channels.
Campaign Design
Owned multi-channel strategy across direct mail, SMS, email, events, and community partnerships. Tailored messaging to drive awareness, registration, and first-time appointment booking, particularly among high-risk members with chronic health needs and social barriers.
Operational Frameworks
Developed scalable processes, including member segmentation, a real-time feedback loop to product and leadership, and localized compliance-aware outreach playbooks.
Quantifiable Impact:
Increased activation metrics by 9% within 90 days through door-to-door outreach, community events, and personalized follow-ups, establishing a model later scaled across multiple states.
This initiative positioned Babylon as a trusted digital health partner in Medicaid markets while proving the ROI of community-led marketing. My approach combined strategic planning, executional excellence, and data-informed decision-making to drive healthcare engagement in high-risk populations.
There are always some stocks, which illusively scale lofty heights in a given time period. However, the good show doesn’t last for these overblown toxic stocks as their current price is not justified by their fundamental strength.
Strategy
A strategy is a general plan to achieve one or more long-term. labore et dolore magna aliqua.
Design
UI/UX Design, Art Direction, A design is a plan or specification for art. which illusively scale lofty heights.
User Experience
User experience (UX) design is the process design teams use to create products that provide.
Toxic companies are usually characterized by huge debt loads and are vulnerable to external shocks. Accurately identifying such bloated stocks and getting rid of them at the right time can protect your portfolio.
Overpricing of these toxic stocks can be attributed to either an irrational enthusiasm surrounding them or some serious fundamental drawbacks. If you own such bubble stocks for an inordinate period of time, you are bound to see a massive erosion of wealth.
Screen OneScreen Two
However, if you can precisely spot such toxic stocks, you may gain by resorting to an investing strategy called short selling. This strategy allows one to sell a stock first and then buy it when the price falls.
While short selling excels in bear markets, it typically loses money in bull markets.
So, just like identifying stocks with growth potential, pinpointing toxic stocks and offloading them at the right time is crucial to guard one’s portfolio from big losses or make profits by short selling them. Heska Corporation HSKA, Tandem Diabetes Care, Inc. TNDM, Credit Suisse Group CS,Zalando SE ZLNDY and Las Vegas Sands LVS are a few such toxic stocks.Screening Criteria
Here is a winning strategy that will help you to identify overhyped toxic stocks:
Most recent Debt/Equity Ratio greater than the median industry average: High debt/equity ratio implies high leverage. High leverage indicates a huge level of repayment that the company has to make in connection with the debt amount.
There are always some stocks, which illusively scale lofty heights in a given time period. However, the good show doesn’t last for these overblown toxic stocks as their current price is not justified by their fundamental strength.
Strategy
A strategy is a general plan to achieve one or more long-term. labore et dolore magna aliqua.
Design
UI/UX Design, Art Direction, A design is a plan or specification for art. which illusively scale lofty heights.
User Experience
User experience (UX) design is the process design teams use to create products that provide.
Toxic companies are usually characterized by huge debt loads and are vulnerable to external shocks. Accurately identifying such bloated stocks and getting rid of them at the right time can protect your portfolio.
Overpricing of these toxic stocks can be attributed to either an irrational enthusiasm surrounding them or some serious fundamental drawbacks. If you own such bubble stocks for an inordinate period of time, you are bound to see a massive erosion of wealth.
Screen OneScreen Two
However, if you can precisely spot such toxic stocks, you may gain by resorting to an investing strategy called short selling. This strategy allows one to sell a stock first and then buy it when the price falls.
While short selling excels in bear markets, it typically loses money in bull markets.
So, just like identifying stocks with growth potential, pinpointing toxic stocks and offloading them at the right time is crucial to guard one’s portfolio from big losses or make profits by short selling them. Heska Corporation HSKA, Tandem Diabetes Care, Inc. TNDM, Credit Suisse Group CS,Zalando SE ZLNDY and Las Vegas Sands LVS are a few such toxic stocks.Screening Criteria
Here is a winning strategy that will help you to identify overhyped toxic stocks:
Most recent Debt/Equity Ratio greater than the median industry average: High debt/equity ratio implies high leverage. High leverage indicates a huge level of repayment that the company has to make in connection with the debt amount.
Through a wide variety of mobile applications, we’ve developed a unique visual system and strategy that can be applied across the spectrum of available applications.
So, just like identifying stocks with growth potential, pinpointing toxic stocks and offloading them at the right time is crucial to guard one’s portfolio from big losses or make profits by short selling them.
Heska Corporation HSKA, Tandem Diabetes Care, Inc. TNDM, Credit Suisse Group CS,Zalando SE ZLNDY and Las Vegas Sands LVS are a few such toxic stocks.Screening Criteria
Through a wide variety of mobile applications, we’ve developed a unique visual system and strategy that can be applied across the spectrum of available applications.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commod viverra maecenas accumsan lacus vel facilisis. ut labore et dolore magna aliqua.
There are always some stocks, which illusively scale lofty heights in a given time period. However, the good show doesn’t last for these overblown toxic stocks as their current price is not justified by their fundamental strength.
Toxic companies are usually characterized by huge debt loads and are vulnerable to external shocks. Accurately identifying such bloated stocks and getting rid of them at the right time can protect your portfolio.
Overpricing of these toxic stocks can be attributed to either an irrational enthusiasm surrounding them or some serious fundamental drawbacks. If you own such bubble stocks for an inordinate period of time, you are bound to see a massive erosion of wealth.
However, if you can precisely spot such toxic stocks, you may gain by resorting to an investing strategy called short selling. This strategy allows one to sell a stock first and then buy it when the price falls.
While short selling excels in bear markets, it typically loses money in bull markets.
So, just like identifying stocks with growth potential, pinpointing toxic stocks and offloading them at the right time is crucial to guard one’s portfolio from big losses or make profits by short selling them. Heska Corporation HSKA, Tandem Diabetes Care, Inc. TNDM, Credit Suisse Group CS,Zalando SE ZLNDY and Las Vegas Sands LVS are a few such toxic stocks.Screening Criteria
Through a wide variety of mobile applications, we’ve developed a unique visual system and strategy that can be applied across the spectrum of available applications.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commod viverra maecenas accumsan lacus vel facilisis. ut labore et dolore magna aliqua.
There are always some stocks, which illusively scale lofty heights in a given time period. However, the good show doesn’t last for these overblown toxic stocks as their current price is not justified by their fundamental strength.
Toxic companies are usually characterized by huge debt loads and are vulnerable to external shocks. Accurately identifying such bloated stocks and getting rid of them at the right time can protect your portfolio.
Overpricing of these toxic stocks can be attributed to either an irrational enthusiasm surrounding them or some serious fundamental drawbacks. If you own such bubble stocks for an inordinate period of time, you are bound to see a massive erosion of wealth.
However, if you can precisely spot such toxic stocks, you may gain by resorting to an investing strategy called short selling. This strategy allows one to sell a stock first and then buy it when the price falls.
While short selling excels in bear markets, it typically loses money in bull markets.
So, just like identifying stocks with growth potential, pinpointing toxic stocks and offloading them at the right time is crucial to guard one’s portfolio from big losses or make profits by short selling them. Heska Corporation HSKA, Tandem Diabetes Care, Inc. TNDM, Credit Suisse Group CS,Zalando SE ZLNDY and Las Vegas Sands LVS are a few such toxic stocks.Screening Criteria
Through a wide variety of mobile applications, we’ve developed a unique visual system and strategy that can be applied across the spectrum of available applications.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida. Risus commod viverra maecenas accumsan lacus vel facilisis. ut labore et dolore magna aliqua.
There are always some stocks, which illusively scale lofty heights in a given time period. However, the good show doesn’t last for these overblown toxic stocks as their current price is not justified by their fundamental strength.
Toxic companies are usually characterized by huge debt loads and are vulnerable to external shocks. Accurately identifying such bloated stocks and getting rid of them at the right time can protect your portfolio.
Overpricing of these toxic stocks can be attributed to either an irrational enthusiasm surrounding them or some serious fundamental drawbacks. If you own such bubble stocks for an inordinate period of time, you are bound to see a massive erosion of wealth.
However, if you can precisely spot such toxic stocks, you may gain by resorting to an investing strategy called short selling. This strategy allows one to sell a stock first and then buy it when the price falls.
While short selling excels in bear markets, it typically loses money in bull markets.
So, just like identifying stocks with growth potential, pinpointing toxic stocks and offloading them at the right time is crucial to guard one’s portfolio from big losses or make profits by short selling them. Heska Corporation HSKA, Tandem Diabetes Care, Inc. TNDM, Credit Suisse Group CS,Zalando SE ZLNDY and Las Vegas Sands LVS are a few such toxic stocks.Screening Criteria